Zepbound Vials Drop, Amycretin Surges, FDA Fast Track, and a Dangerous Trend // TWD 6.17.25

Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!

Share Zepbound Vials Drop, Amycretin Surges, FDA Fast Track, and a Dangerous Trend // TWD 6.17.25

Sign up to save your podcasts

Zepbound Vials Drop, Amycretin Surges, FDA Fast Track, and a Dangerous Trend // TWD 6.17.25

Zepbound Vials Drop, Amycretin Surges, FDA Fast Track, and a Dangerous Trend // TWD 6.17.25

More shows like On The Pen With Dave Knapp

Everyday Wellness with Cynthia Thurlow ™

The Hormone Solution with Karen Martel

The Holistic GLP-1 Podcast with Elizabeth McGann

The Hunter Williams Podcast

The Thyroid Fixer

LONGEVITY with Nathalie Niddam

The Dr. Tyna Show

Docs Who Lift

The Peptide Podcast

The Dr. Francavilla Show

The Obesity Guide with Matthea Rentea MD

The Plus SideZ: Cracking the Obesity Code

Game-Changing Health

Fat Science

GLP-1 Hub: Support, Community, and Weight Loss